| Literature DB >> 35875731 |
Karrar Hameed Abdulkareem1,2, Ammar Awad Mutlag3, Ahmed Musa Dinar4, Jaroslav Frnda5,6, Mazin Abed Mohammed7, Fawzi Hasan Zayr8, Abdullah Lakhan9, Seifedine Kadry10, Hasan Ali Khattak11, Jan Nedoma6.
Abstract
COVID-19 has depleted healthcare systems around the world. Extreme conditions must be defined as soon as possible so that services and treatment can be deployed and intensified. Many biomarkers are being investigated in order to track the patient's condition. Unfortunately, this may interfere with the symptoms of other diseases, making it more difficult for a specialist to diagnose or predict the severity level of the case. This research develops a Smart Healthcare System for Severity Prediction and Critical Tasks Management (SHSSP-CTM) for COVID-19 patients. On the one hand, a machine learning (ML) model is projected to predict the severity of COVID-19 disease. On the other hand, a multi-agent system is proposed to prioritize patients according to the seriousness of the COVID-19 condition and then provide complete network management from the edge to the cloud. Clinical data, including Internet of Medical Things (IoMT) sensors and Electronic Health Record (EHR) data of 78 patients from one hospital in the Wasit Governorate, Iraq, were used in this study. Different data sources are fused to generate new feature pattern. Also, data mining techniques such as normalization and feature selection are applied. Two models, specifically logistic regression (LR) and random forest (RF), are used as baseline severity predictive models. A multi-agent algorithm (MAA), consisting of a personal agent (PA) and fog node agent (FNA), is used to control the prioritization process of COVID-19 patients. The highest prediction result is achieved based on data fusion and selected features, where all examined classifiers observe a significant increase in accuracy. Furthermore, compared with state-of-the-art methods, the RF model showed a high and balanced prediction performance with 86% accuracy, 85.7% F-score, 87.2% precision, and 86% recall. In addition, as compared to the cloud, the MAA showed very significant performance where the resource usage was 66% in the proposed model and 34% in the traditional cloud, the delay was 19% in the proposed model and 81% in the cloud, and the consumed energy was 31% in proposed model and 69% in the cloud. The findings of this study will allow for the early detection of three severity cases, lowering mortality rates.Entities:
Mesh:
Year: 2022 PMID: 35875731 PMCID: PMC9297127 DOI: 10.1155/2022/5012962
Source DB: PubMed Journal: Comput Intell Neurosci
Clinical, laboratory, vital functions, and medical history information collected from hospitals records.
| Characteristics | Overall appearance |
|---|---|
| Age, mean (years) | 52.83 |
|
| |
|
| |
| Male | 46 (58.97%) |
| Female | 32 (41.03%) |
|
| |
|
| |
| Chronic medical illness (hypertension; diabetes; tumour or any type of cancer) | 41 (52.56%) |
|
| |
|
| |
| Mortality rate | 11 (14.1%) |
| Survival rate | 67 (85.9%) |
|
| |
|
| |
| Fever | 53 (67.95%) |
| Cough | 46 (58.97%) |
| Generalized weakness | 52 (66.67%) |
| Nasal congestion | 33 (42.30%) |
| Rhinorrhoea | 33 (42.30%) |
| Sneezing | 44 (56.41%) |
| Sore throat | 45 (57.69%) |
| Pleuritic chest pain | 42 (53.84%) |
| Diarrhoea | 41 (52.56%) |
| Lost sense of smell | 71 (91.02%) |
| Lost sense of taste | 72 (92.30%) |
|
| |
|
| |
| Haemoglobin (g/dL) | M: 11 (23.91%), F: 15 (46.87%) |
| White blood cell count | 31 (39.74%) |
| Lymphocyte count | 13 (16.66%) |
| Platelet count | 13 (16.66%) |
| C-reactive protein (mg/L) | 48 (61.53%) |
| Urea (mmol/L) | 22 (28.20%) |
| Creatinine ( | 56 (71.79%) |
|
| |
|
| |
| Saturation of oxygen in the blood (SPO2), (>90, 90–94, 95–100) | 46 (58.97%), 21 (26.93%), 11 (14.10%) |
Figure 1Smart Healthcare System for Severity Prediction and Critical Tasks Management (SHSSP-CTM) of COVID-19 patients.
Figure 2COVID-19 severity prediction.
COVID-19 severity prediction based on demographic feature set.
| Model | AUC | Accuracy | F1 | Precision | Recall |
|---|---|---|---|---|---|
| RF | 58 | 50 | 49.7 | 49.6 | 50 |
| LR | 60.9 | 58.9 | 52.8 | 69 | 58.9 |
COVID-19 severity prediction based on chronic condition feature set.
| Model | AUC | Accuracy | F1 | Precision | Recall |
|---|---|---|---|---|---|
| RF | 54.8 | 47.4 | 39.1 | 48.6 | 47.4 |
| LR | 54.2 | 48.7 | 35 | 41.5 | 48.7 |
COVID-19 severity prediction based on symptom feature set.
| Model | AUC | Accuracy | F1 | Precision | Recall |
|---|---|---|---|---|---|
| RF | 67.6 | 56.4 | 54.6 | 55.7 | 56.4 |
| LR | 56.2 | 44.8 | 41.4 | 40.2 | 44.8 |
COVID-19 severity prediction based on laboratory finding feature set.
| Model | AUC | Accuracy | F1 | Precision | Recall |
|---|---|---|---|---|---|
| RF | 88.3 | 75.6 | 75.9 | 76.6 | 75.6 |
| LR | 86.6 | 73 | 73 | 73 | 73 |
COVID-19 severity prediction based on vital sign feature set.
| Model | AUC | Accuracy | F1 | Precision | Recall |
|---|---|---|---|---|---|
| RF | 88.3 | 75.6 | 75.9 | 76.6 | 75.6 |
| LR | 86.6 | 73 | 73 | 73 | 73 |
COVID-19 severity prediction depending on feature fusion.
| Model | AUC | Accuracy | F1 | Precision | Recall |
|---|---|---|---|---|---|
| RF | 83.3 | 78.2 | 77.8 | 78.5 | 78.2 |
| LR | 87.1 | 74.3 | 74.2 | 74.5 | 74.3 |
COVID-19 severity prediction depending on feature fusion and selection protocol.
| Model | AUC | Accuracy | F1 | Precision | Recall |
|---|---|---|---|---|---|
| RF | 93 | 86 | 85.7 | 87.2 | 86 |
| LR | 90.3 | 79.4 | 79.5 | 79.6 | 79.4 |
Overall accuracy improvements.
| Model | Demographic | Chronic | Symptoms | Laboratory | Vital signs | Average of five sets | Fusion set | Fusion and selection protocol |
|---|---|---|---|---|---|---|---|---|
| RF | 50 | 47 | 56 | 75 | 67 | 59 | 78 | 86 |
| LR | 58 | 48 | 44 | 73 | 71 | 59 | 74 | 79 |
Figure 3RF confusion matrix.
Figure 4LR confusion matrix.
Figure 5ROC for mild class.
Figure 6ROC for moderate class.
Figure 7ROC for sever class.
Figure 8Resource usage.
Figure 9Delay.
Comparison of benchmarked studies.
| Study | Prediction model | AUC | Accuracy | F1 | Precision | Recall |
|---|---|---|---|---|---|---|
| [ | RF | n/a | 70 | n/a | n/a | n/a |
| SVM | n/a | 80 | n/a | n/a | n/a | |
| LR | n/a | 50 | n/a | n/a | n/a | |
|
| ||||||
| [ | NN | 78.2 | n/a | 41.3 | 48.6 | n/a |
| LR |
| n/a | 60.4 | 76.4 | n/a | |
|
| ||||||
| Our | RF | 93 |
|
|
|
|
| SVM | 91 | 79.4 | 79.1 | 81 | 79.4 | |
| NN | 86.4 | 79.4 | 79.4 | 79.7 | 79.4 | |
| LR | 90.3 | 79.4 | 79.5 | 79.6 | 79.4 | |